CompletedNot Applicable

Global Evaluation of Cholecystectomy Knowledge and Outcomes, Indonesia

Indonesia92 participantsStarted 2023-07-31

Plain-language summary

GECKO is a prospective, international, multicentre, observational cohort study delivered by GlobalSurg Collaborative. This will be on consecutive patients undergoing cholecystectomy, between 31st July 2023 to 19th November 2023, with follow-up at 30-day and one-year postoperatively. Mini-teams of up to five collaborators per 14-day data collection period will prospectively collect data at each participating centre. The primary aim is to define the global variation in compliance to pre-, intra-, and post-operative audit standards. The subjects will be observed and interviewed during pre-surgery hospitalization up to one-year post-surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All adult patients (greater than or including 18 years of age) * Undergo primary cholecystectomy (as the main procedure) * Any open, laparoscopic, robotic approaches are eligible * Elective, delayed and emergency cholecystectomy Exclusion Criteria: * Cholecystectomy as a part of another surgical procedure (Whipple's, bariatric, transplant) * Patients with Mirizzi syndrome * Patients returning to theatre and requiring a cholecystectomy for whatever indication * Known gallbladder malignancy: Gallbladder cancer diagnosed preoperatively

What they're measuring

30-day mortality

Timeframe: 30 days after the surgery

1-year mortality

Timeframe: 1 year after the surgery

Trial details

NCT IDNCT06183346

SponsorUdayana University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Cholecystectomy trials